These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15049929)

  • 1. Impaired fasting glycaemia vs. impaired glucose tolerance: two sides of the same coin with implications for cardiovascular risk.
    Lim HS; Lip GY
    Diabet Med; 2004 Apr; 21(4):303-4. PubMed ID: 15049929
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired fasting glycaemia resembles impaired glucose tolerance with regard to cardiovascular risk factors: population-based, cross-sectional study of risk factors for cardiovascular disease.
    Heldgaard PE; Olivarius Nde F; Hindsberger C; Henriksen JE
    Diabet Med; 2004 Apr; 21(4):363-70. PubMed ID: 15049940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impaired glucose tolerance (IGT): current understanding and future research directions].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():21-6. PubMed ID: 15779340
    [No Abstract]   [Full Text] [Related]  

  • 4. Impaired glucose tolerance, impaired fasting glycaemia and cardiovascular risk.
    Sanusi H
    Acta Med Indones; 2004; 36(1):36-41. PubMed ID: 15673935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose.
    Santaguida PL; Balion C; Hunt D; Morrison K; Gerstein H; Raina P; Booker L; Yazdi H
    Evid Rep Technol Assess (Summ); 2005 Aug; (128):1-11. PubMed ID: 16194123
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired glucose tolerance and impaired fasting glucose--a review of diagnosis, clinical implications and management.
    Petersen JL; McGuire DK
    Diab Vasc Dis Res; 2005 Feb; 2(1):9-15. PubMed ID: 16305067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].
    Igarashi M; Tominaga M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():55-60. PubMed ID: 15779345
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.
    Liu J; Joshi D; Sempos CT
    Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose especially when they are obese: the ADDITION Netherlands study.
    Janssen PG; Gorter KJ; Stolk RP; Rutten GE
    Prim Care Diabetes; 2007 Jun; 1(2):69-74. PubMed ID: 18632022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial.
    Fontbonne A; Diouf I; Baccara-Dinet M; Eschwege E; Charles MA
    Diabetes Metab; 2009 Nov; 35(5):385-91. PubMed ID: 19665415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impaired glucose tolerance in nonalcoholic fatty liver disease].
    Taguchi M; Otsuki M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():291-4. PubMed ID: 15779390
    [No Abstract]   [Full Text] [Related]  

  • 14. [IFG and IGT in Europe and America: the present and prospective].
    Tsujii S; Kuzuya H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():27-33. PubMed ID: 15779341
    [No Abstract]   [Full Text] [Related]  

  • 15. The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk.
    Retnakaran R; Qi Y; Connelly PW; Sermer M; Hanley AJ; Zinman B
    J Clin Endocrinol Metab; 2010 Sep; 95(9):4345-53. PubMed ID: 20631030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
    Saaristo T; Peltonen M; Lindström J; Saarikoski L; Sundvall J; Eriksson JG; Tuomilehto J
    Diab Vasc Dis Res; 2005 May; 2(2):67-72. PubMed ID: 16305061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAI-1 and the metabolic syndrome: links, causes, and consequences.
    Alessi MC; Juhan-Vague I
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2200-7. PubMed ID: 16931789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of dysglycaemia and cardiovascular disease in patients with metabolic syndrome.
    Gong W; Yang Z; Ye W; Du Y; Lu B; Wang M; Li Q; Zhang W; Pan Y; Feng X; Zhou W; Zhang Y; Wen J; Yang Z; Yang Y; Zhu X; Hu R
    J Int Med Res; 2009; 37(5):1486-92. PubMed ID: 19930855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High predictability of impaired glucose tolerance by combining cardiometabolic screening parameters in obese children.
    Groot CJ; Grond JV; Delgado Y; Rings EH; Hannema SE; van den Akker EL
    J Pediatr Endocrinol Metab; 2017 Feb; 30(2):189-196. PubMed ID: 28076317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of postpartum carbohydrate intolerance and cardiovascular risk factors in women with gestational diabetes.
    Akinci B; Celtik A; Genc S; Yener S; Demir T; Secil M; Kebapcilar L; Yesil S
    Gynecol Endocrinol; 2011 May; 27(5):361-7. PubMed ID: 20540676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.